vTv Therapeutics, Inc. (VTVT): Price/Earnings to Growth Multiple

Symbol and logo of brand vTv Therapeutics Inc (VTVT)

The strategic priority of vTv Therapeutics Inc. (VTVT) is to ensure stable international component supplies and protect its patents. The history of the PEG ratio reflects progress in this direction, where 0.00 represents the latest level of the metric. However, the potential for profit from royalties and insurance payouts is constrained by strict regulatory control and the current trial stage of new metabolism drugs.

VTVT vTv Therapeutics Inc. Price/Earnings to Growth Multiple (07/04/2022 - 11/17/2026)

Analytical breakdowns for vTv Therapeutics (VTVT)

- share price and consensus valuation forecast:
Fundamental company analysis:VTVT - vTv Therapeutics Inc.
Signature product of vtvtherapeutics.com

The PEG ratio compares a business's market value to its earnings growth rate. By analyzing the PEG ratio, an investor determines whether they are overpaying for future expansion. The calculation is based on dividing the P/E ratio by the annual EPS growth percentage. For vTv Therapeutics Inc. (VTVT), this indicator is critical, as FDA approval would ensure explosive revenue scaling with minimal capital expenditures.

Competitors of vTv Therapeutics Inc.

ASND (Ascendis) - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio madrigalpharma.com MDGL|CORT - Price/Earnings to Growth Multiple|Rhythm Corp - PEG Multiple|Price to Earnings Adjusted for Growth Rate Akero Therapeutics Inc|MTSR (Metsera) - Price/Earnings to Growth Multiple|MLTX: Company Value to Earnings Growth Ratio|CRNX (Crinetics Corp) - PEG Multiple|PEG Multiple NewAmsterdam Pharma|PEG Multiple SLNO|Price/Earnings to Growth Ratio FOLD (Amicus Therapeutics Inc)|Price/Earnings to Growth Ratio 89bio.com ETNB|Agios Corp (AGIO) - Price to Earnings Adjusted for Growth Rate|GPCR - Price/Earnings to Growth Ratio|MDXG: Price/Earnings to Growth Ratio|RZLT: PEG Multiple|LXRX - Growth-Adjusted Market Cap to Net Income|Price/Earnings to Growth Ratio MBX Corp|Price/Earnings to Growth Multiple Altimmune Corp (ALT)|Price/Earnings to Growth Ratio aardvarktherapeutics.com (AARD)|Price/Earnings to Growth Multiple sagimet.com SGMT|PEG Multiple BIOA (BioAge)|Biomea Fusion - Price/Earnings to Growth Ratio|QNCX: Price/Earnings to Growth Multiple|Growth-Adjusted Payback Ratio GUTS (Fractyl)|ATPC: PEG Multiple|Pluri Inc (PLUR) - PEG Multiple|Price/Earnings to Growth Ratio Synlogic, Inc.|Price to Earnings Adjusted for Growth Rate Lipocine LPCN|Price/Earnings to Growth Ratio Matinas BioPharma Holdings Inc. (MTNB)|Price/Earnings to Growth Multiple Spruce Biosciences SPRB|Galecto Corp - Price/Earnings to Growth Multiple|carmellrx.com - Price/Earnings to Growth Ratio|LUMO - Price/Earnings to Growth Ratio|ONVO: Price/Earnings to Growth Ratio|Radius Health (RDUS) - Price/Earnings to Growth Ratio